BHVN

Biohaven Pharmaceutical Holding Company Ltd

Halal Rating :
Comfortable
Last Price $37.61 Last updated:
Market Cap -
7D Change 0.35%
1 Year Change -22.37%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange
Next Earnings Date

Biohaven Pharmaceutical Holding Company Ltd is a clinical-stage biopharmaceutical company focusing on the development and commercialization of innovative treatments for neurological and neuropsychiatric diseases. The company's primary focus is on developing novel therapies for conditions with significant unmet medical needs.

The company is currently developing treatments across several therapeutic categories, including neurology, rare disorders, and immune-mediated diseases. Their pipeline includes multiple drug candidates in various stages of clinical development.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio

Company Impact

Help us evaluate Biohaven Pharmaceutical Holding Company Ltd's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates